Effects of low frequency filtering on distal compound muscle action potential duration for diagnosis of CIDP: A Japanese-European multicenter prospective study

Clinical Neurophysiology

Volumn 126, Issue 9, 2015, Pages 1805-1810

  Mitsuma, Satsuki ^a   Van den Bergh, Peter ^b   Rajabally, Yusuf A ^c   Van Parijs, Vinciane ^b   Martin Lamb, Darren ^c   Sonoo, Masahiro ^d   Inaba, Akira ^e   Shimizu, Toshio ^f   Isose, Sagiri ^a   Sato, Yasunori ^a   Komori, Tetsuo ^g   Misawa, Sonoko ^a   Kuwabara, Satoshi ^a   Kuwabara, S ^h   Isose, S ^h   Misawa, S ^h   Sekiguchi, Y ^h   Shibuya, K ^h   Sonoo, M ⁱ   Shimizu, T ^f   Komori, T ^g   Abe, T ^g   Inaba, A ^e   Yokota, T ^j   Kanouchi, T ^j   Kokubun, N ^k   Nagashima, T ^k   Tamura, A ^l   Ohishi, C ^m   Hirashima, F ⁿ   more..

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Mutual Aid Association of Public School Teachers   (Japan)

^f TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^g Hakone National Hospital   (Japan)

^h Ciba University   (Japan)

ⁱ TEIKYO UNIVERSITY   (Japan)

^j TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^k DOKKYO MEDICAL UNIVERSITY   (Japan)

^l Department of Pediatrics   (Japan)

^m KYORIN UNIVERSITY   (Japan)

ⁿ Nissan Tamagawa Hospital   (Japan)

more..

Author keywords

Chronic inflammatory demyelinating polyneuropathy; CIDP; Demyelination; Distal compound muscle action potential duration; Electrodiagnosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMYELINATION; DIABETIC NEUROPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISTAL COMPOUND MUSCLE ACTION POTENTIAL; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIAN NERVE; MOTOR NERVE CONDUCTION; MULTICENTER STUDY; MUSCLE ACTION POTENTIAL; NERVE ENDING; PERONEUS NERVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TERTIARY CARE CENTER; ULNAR NERVE; ACTION POTENTIAL; CLINICAL TRIAL; EPIDEMIOLOGY; EUROPE; INTERNATIONAL COOPERATION; JAPAN; MIDDLE AGED; NERVE CONDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ACTION POTENTIALS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; ELECTROMYOGRAPHY; EUROPE; FEMALE; HUMANS; INTERNATIONALITY; JAPAN; MALE; MIDDLE AGED; NEURAL CONDUCTION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84938949452     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2014.11.027     Document Type: Article

References (19)

1. Akobeng A.K. Understanding diagnostic test 3. Acta Paediatr 2007, 96:644-647.
2. Cleland J.C., Logigian E.L., Thaisetthawatkul P., Herrmann D.N. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome. Muscle Nerve 2003, 28:189-193.
3. Dyck P.J., Litchy W.J., Kratz K.M., Suarez G.A., Low P.A., Pineda A.A., et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994, 36:838-845.
4. Fluss R., Faraggi D., Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J 2005, 47:458-472.
5. Hashimoto S., Kawamura J., Segawa Y., Harada Y., Hanakawa T., Osaki Y. Waveform changes of compound muscle action potential (CMAP) with muscle length. J Neurol Sci 1994, 124:21-24.
6. Hughes R.A., Bouche P., Cornblath D.R., Evers E., Hadden R.D., Hahn A., et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2006, 11:9-19.
7. Isose S., Kuwabara S., Kokubun N., Sato Y., Mori M., Shibuya K., et al. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peripher Nerv Syst 2009, 14:151-158.
8. Isose S., Misawa S., Sonoo M., Shimizu T., Ohishi C., Shibuya K., et al. Duration of the distal compound muscle action potential for diagnosis of chronic inflammatory demyelinating polyneuropathy: effects of low-cut filters. J Clin Neurophysiol 2014, 31:441-443.
9. Jonckheere A.R. A distribution-free k-sample test against ordered alternatives. Biometrika 1954, 41:133-145.
10. Kimura J. Electrodiagnosis in diseases of nerve and muscle principles and practice 2001, Oxford University Press. 4th ed.
11. Kuwabara S., Ogawara K., Misawa S., Mori M., Hattori T. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002, 72:37-42.
12. Kuwabara S., Misawa S. Chronic inflammatory demyelinating polyneuropathy: clinical subtypes and their correlation with electrophysiology. Clin Exp Neuroimmunol 2011, 2:41-48.
13. Perkins N.J., Schisternam E.F. The inconsistency of optimal cut points obtained using two criteria based on the receiver operating characteristics curve. Am J epidemiol 2006, 163:670-675.
14. Rajabally Y.A., Lagarde J., Cassereau J., Viala K., Fournier E., Nicolas G. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol 2012, 19:638-642.
15. Saperstein D.S., Amato A.A., Wolfe G.I., Katz J.S., Nations S.P., Jackson C.E., et al. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999, 22:560-566.
16. Saperstein D.S., Katz J.S., Amato A.A., Barohn R.J. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001, 24:311-324.
17. Schisterman E.F., Faraggi D., Reiser B., Trevisan M. Statistical inference for the area under the receiver operating characteristic curve in the presence of random measurement error. Am J Epidemiol 2001, 154:174-179.
18. Thaisetthawatkul P., Logigian E.L., Herrmann D.N. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology 2002, 59:1526-1532.
19. Van den Bergh P.Y., Hadden R.D., Bouche P., Cornblath D.R., Hahn A., Illa I., et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2010, 15:1-9.